Tag: Therapeutics

(NASDAQ:RLAY) Chief Monetary Officer Thomas Catinazzo offered 17,717 shares of frequent inventory on April 7, 2026, at costs starting from ...

Comply withPlay Earnings NamePlay Earnings Name Aligos Therapeutics, Inc. (ALGS) Jefferies London Healthcare Convention 2025 November 17, 2025 10:00 AM ...

In latest months, Wall Road has seen a surge of healthcare corporations searching for to go public, as IPO exercise ...

Windtree Therapeutics might be delisted from the Nasdaq Capital Market after failing to fulfill itemizing necessities, a call that triggered ...

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical firm engaged within the improvement of focused radiotherapeutics for difficult-to-treat cancers. Presently, it's ...

Faruqi & Faruqi, LLP Securities Litigation Accomplice James (Josh) Wilson Encourages Buyers Who Suffered Losses Exceeding $50,000 In Kyverna To ...

In a difficult yr for Allarity Therapeutics Inc, the biotechnology agency's inventory has plummeted to a 52-week low, touching a ...

Depth Therapeutics, Inc. (NASDAQ: INTS) is a scientific biotechnology firm engaged within the discovery improvement, and commercialization of first-in-class most ...

Design Therapeutics Inc. (DSGN) has reached a brand new 52-week excessive, with its inventory worth climbing to $6.91. This milestone ...